Colonoscopy Bowel Preparation Drugs Market to Surpass US$ 2.4 Billion, Globally, by the End of 2027 - Coherent Market Insights

News provided by

Mar 20, 2020, 09:54 ET

SEATTLE, March 20, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global colonoscopy bowel preparation drugs market was valued at US$ 1,574.9 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027).

Key Trends and Analysis of the Colonoscopy Bowel Preparation Drugs Market:

Key trends in the market include rising prevalence of colorectal cancer and increasing adoption of growth strategies such as acquisitions, collaborations, and product launches by the market players.

The increasing incidence of chronic gastrointestinal disorders such as colorectal cancer is expected to drive growth of the global colonoscopy bowel preparation drugs market during the forecast period. For instance, according to the World Health Organization 2020 statistics, globally, colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with around 1.8 million new cases of colorectal cancer diagnosed in 2018 and almost 861,000 deaths occurred in 2018.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3641

Several market players are focused on product launches, which is expected to propel the market growth. For instance, in September 2018, Salix Pharmaceuticals, Ltd., an operating division of Bausch Health Companies Inc., launched PLENVU, the first and only 1 liter PEG bowel cleansing preparation for colonoscopies in the U.S.

Moreover, increasing adoption of partnerships and acquisition strategies by market players is expected to propel the market growth over the forecast period. For instance, in February 2019, Bausch Health Companies Inc. acquired certain assets of Synergy Pharmaceuticals Inc., a company focusing on the development of drugs to treat gastrointestinal disorders. As a result of this acquisition, it expanded the gastrointestinal product portfolio of Bausch Health Companies Inc. and its presence in the global market.

Key Market Takeaways:

The global colonoscopy bowel preparation drugs market is expected to exhibit a CAGR of 4.9% during the forecast period (2019-2027), owing to rising prevalence of colorectal cancer. For instance, according to the World Health Organization 2020 statistics, globally, colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with around 1.8 million new cases of colorectal cancer diagnosed in 2018 and almost 861,000 deaths occurred in 2018.
Key players are focused on adopting growth strategies such as product launches, collaborations, and acquisitions for enhancing their product offerings in the potential market, which in turn is expected to propel the market growth over the forecast period. For instance, in February 2020, Norgine B.V. entered into an exclusive license and distribution agreement with Faes Farma S.A., for the distribution and commercialization of PLENVU, a colon cleansing preparation, in Latin America.

Key players operating in the global colonoscopy bowel preparation drugs market include—

Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.

Buy this Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/3641

Market Segmentations:

Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type:

Isosmotic Agents

High-volume Polyethylene Glycol Preparations
Sulfate-free PEG-ELS
Low-volume PEG Preparations

Hyposmotic Agents
Hyperosmotic Agents

Oral sodium Sulfate
Magnesium Citrate
Sodium Phosphate

Combination Agents

Sodium Picosulfate/Magnesium Citrate
Sodium Sulfate and SF-PEG-ELS

Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel:

Hospitals Pharmacies
Retail Pharmacies
Others

Global Colonoscopy Bowel Preparation Drugs Market, By Region:

North America

U.S.
Canada

Latin America

Brazil
Mexico
Argentina
Rest of Latin America

Europe

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

GCC
Israel
Rest of Middle East

Africa

South Africa
Central Africa
North Africa

Did not find what you were looking for? Here are some other topics might be of your interest:

LYSOSOMAL STORAGE DISEASES THERAPEUTICS MARKET

The deficiency of enzymes that causes a specific disease condition called lysosomal storage disease includes diseases such as Fabry Disease, Gaucher disease, lysosomal acid lipase deficiency, mucopolysaccharidosis, Hunter syndrome, and Pompe disease. Enzyme replacement therapy involves intravenous administration of enzymes in order to correct the deficiency of enzymes.

DYSPHAGIA MANAGEMENT MARKET

Difficulty in swallowing foods or liquids is termed as dysphagia. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Dysphagia is caused due to oral, esophageal or oropharyngeal cancer and is more common in patient suffering from stroke.

EUROPE PHARMACEUTICAL DRUGS MARKET

Pharmaceutical drugs are composed of chemical compounds which are used for prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, and other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trial, drug safety, efficacy and marketing in European region.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

SOURCE Coherent Market Insights